Article citationsMore>>

Sava, G., Bergamo, A., Zorzet, S., Gava, B., Casarsa, C., Cocchietto, M., Furlani, A., Scarcia, V., Serli, B., Iengo, E., Alessio, E. and Mestroni, G. (2002) Influence of Chemical Stability on the Activity of the Antimetastasis Ruthenium Compound NAMI-A. European Journal of Cancer, 38, 427-435.
https://doi.org/10.1016/S0959-8049(01)00389-6

has been cited by the following article:

• TITLE: Theoretical Investigation of Ru(II) Complexes as Photosensitizer for Photodynamic Therapy

  AUTHORS: Bamba Kafoumba, Ouattara Lamoussa, Massapihanhoro Pierre Ouattara, Ouattara Wawohinlin Patrice, Diarrassouba Fatogoma, N’guessan Kouakou Nobel, Ehouman Ahissan Donatien, Ziao Nahossé

  KEYWORDS: TD-DFT, Ru(II), Photo-Dynamic Therapy (PDT), (Un)restricted Model

  JOURNAL NAME: Computational Molecular Bioscience, Vol.12 No.2, June 29, 2022

  ABSTRACT: This work was undertaken to see how Ru II complexes can be suitable for photodynamic therapy through theoretical prediction. For that, four Ru II complexes, α-RuCl2(Azpy)2, , and were used in unrestricted state by providing with no more energy than 2.68 eV. The unrestricted state allows the complex molecule to display each of its electrons in one orbital. All the calculations such as optimization, frequency and TD-DFT calculations were performed at WB97XD/Lanl2dz level. It resulted from this investigation that Ru II complexes are active for both mechanisms suitable for photodynamic therapy in presence or absence of 3O2. Moreover, this reaction was assumed to take place only with Guanine DNA base as demonstrated in literature. Therefore, Guanine is admitted as the base most reacting with ruthenium complexes for photodynamic therapy. This work confirms our prediction regarding metallic complexes that are assumed to be photosensitized in condition that an electron must be isolated to favor the excitation. Nevertheless, Ru II complexes are found suitable for superficial therapy while Ru III must be active for deep therapy.